88 related articles for article (PubMed ID: 23148045)
1. Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis.
McCann MJ; Rowland IR; Roy NC
Mol Nutr Food Res; 2013 Feb; 57(2):212-24. PubMed ID: 23148045
[TBL] [Abstract][Full Text] [Related]
2. Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro.
McCann MJ; Gill CI; Linton T; Berrar D; McGlynn H; Rowland IR
Mol Nutr Food Res; 2008 May; 52(5):567-80. PubMed ID: 18398867
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model.
Quader ST; Bello-DeOcampo D; Williams DE; Kleinman HK; Webber MM
Mutat Res; 2001 Sep; 496(1-2):153-61. PubMed ID: 11551491
[TBL] [Abstract][Full Text] [Related]
4. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
5. The anti-proliferative effects of enterolactone in prostate cancer cells: evidence for the role of DNA licencing genes, mi-R106b cluster expression, and PTEN dosage.
McCann MJ; Rowland IR; Roy NC
Nutrients; 2014 Nov; 6(11):4839-55. PubMed ID: 25372501
[TBL] [Abstract][Full Text] [Related]
6. Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26.
Rivette AS; Tokar EJ; Williams DE; Mackenzie CD; Ablin RJ; Webber MM
J Exp Ther Oncol; 2005; 5(2):111-23. PubMed ID: 16471037
[TBL] [Abstract][Full Text] [Related]
7. Effect of mammalian lignans on the growth of prostate cancer cell lines.
Lin X; Switzer BR; Demark-Wahnefried W
Anticancer Res; 2001; 21(6A):3995-9. PubMed ID: 11911282
[TBL] [Abstract][Full Text] [Related]
8. Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats.
Miura D; Saarinen NM; Miura Y; Santti R; Yagasaki K
Nutr Cancer; 2007; 58(1):49-59. PubMed ID: 17571967
[TBL] [Abstract][Full Text] [Related]
9. Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo.
Danbara N; Yuri T; Tsujita-Kyutoku M; Tsukamoto R; Uehara N; Tsubura A
Anticancer Res; 2005; 25(3B):2269-76. PubMed ID: 16158974
[TBL] [Abstract][Full Text] [Related]
10. Metabolic signatures of malignant progression in prostate epithelial cells.
Teahan O; Bevan CL; Waxman J; Keun HC
Int J Biochem Cell Biol; 2011 Jul; 43(7):1002-9. PubMed ID: 20633696
[TBL] [Abstract][Full Text] [Related]
11. Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether à-go-go-1 potassium channels.
Bernal-Ramos G; Hernández-Gallegos E; Vera E; Chávez-López MG; Zúñiga-García V; Sánchez-Pérez Y; Garrido E; Camacho J
Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):11-13. PubMed ID: 29307346
[TBL] [Abstract][Full Text] [Related]
12. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture.
Mousavi Y; Adlercreutz H
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):615-9. PubMed ID: 1562532
[TBL] [Abstract][Full Text] [Related]
13. Enterolactone glucuronide and β-glucuronidase in antibody directed enzyme prodrug therapy for targeted prostate cancer cell treatment.
Di Y; Ji S; Wolf P; Krol ES; Alcorn J
AAPS PharmSciTech; 2017 Aug; 18(6):2336-2345. PubMed ID: 28116598
[TBL] [Abstract][Full Text] [Related]
14. The role of alpha 6 beta 1 integrin and EGF in normal and malignant acinar morphogenesis of human prostatic epithelial cells.
Bello-DeOcampo D; Kleinman HK; Webber MM
Mutat Res; 2001 Sep; 480-481():209-17. PubMed ID: 11506815
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms.
Hudson TS; Hartle DK; Hursting SD; Nunez NP; Wang TT; Young HA; Arany P; Green JE
Cancer Res; 2007 Sep; 67(17):8396-405. PubMed ID: 17804756
[TBL] [Abstract][Full Text] [Related]
16. Enterolactone has stronger effects than enterodiol on ovarian cancer.
Liu H; Liu J; Wang S; Zeng Z; Li T; Liu Y; Mastriani E; Li QH; Bao HX; Zhou YJ; Wang X; Hu S; Gao S; Qi Y; Shen Z; Wang H; Yu M; Gao T; Johnston RN; Liu SL
J Ovarian Res; 2017 Jul; 10(1):49. PubMed ID: 28738876
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
[TBL] [Abstract][Full Text] [Related]
18. Basal cell induced differentiation of noncancerous prostate epithelial cells (RWPE-1) by glycitein.
Clubbs EA; Bomser JA
Nutr Cancer; 2009; 61(3):390-6. PubMed ID: 19373613
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo.
Saarinen NM; Abrahamsson A; Dabrosin C
Int J Cancer; 2010 Aug; 127(3):737-45. PubMed ID: 19924815
[TBL] [Abstract][Full Text] [Related]
20. Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice.
Power KA; Saarinen NM; Chen JM; Thompson LU
Int J Cancer; 2006 Mar; 118(5):1316-20. PubMed ID: 16152607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
